LEE DAVID A H 4
4 · ENDO PHARMACEUTICALS HOLDINGS INC · Filed Aug 11, 2004
Insider Transaction Report
Form 4
LEE DAVID A H
Sen. V.P., R&D and Regulatory
Transactions
- Exercise/Conversion
Class C2 Stock Option
2004-08-09−497,455→ 78,598 totalExercise: $2.42From: 2004-08-09Exp: 2007-08-26→ Common Stock (497,455 underlying) - Exercise/Conversion
Common Stock, par value $.01 per share
2004-08-09$2.42/sh+497,455$1,203,841→ 497,455 total - Sale
Common Stock, par value$.01 per share
2004-08-09$17.46/sh−497,455$8,685,564→ 0 total
Footnotes (2)
- [F1]The exercisability of 497,455 Class C2 Options was accelerated in connection with an offering of shares that closed on August 9, 2004. The remaining options become exercisable upon the ealier of an Exit Event (as defined in the underlying option plan as filed with the SEC) or January 1, 2006.
- [F2]Common Stock held by Endo Pharma LLC. The exercise of these stock options did not result in the issuance of additional Common Stock by the Issuer.